(Q34731569)

4 August 2017

Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer (English)

1 reference

4 August 2017

1 reference

4

Carrie N Klabunde

1 reference

4 August 2017

Vickie L Shavers

1

1 reference

4 August 2017

Martin L Brown

2

1 reference

4 August 2017

Arnold L Potosky

3

1 reference

4 August 2017

W W Davis

5

1 reference

4 August 2017

Judd W Moul

6

1 reference

4 August 2017

Angela Fahey

7

1 reference

4 August 2017

1 February 2004

1 reference

Journal of General Internal Medicine

4 August 2017

1 reference

4 August 2017

19

1 reference

4 August 2017

146-155

1 reference

4 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1525-1497.2004.30209.x

4 August 2017

0 references

cites work

Utility of the SEER-Medicare data to identify chemotherapy use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Studying radiation therapy using SEER-Medicare-linked data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Use of SEER-Medicare data for measuring cancer surgery

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Prostate cancer: to screen or not to screen?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

PSA screening and prostate cancer mortality.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Racial and ethnic disparities in the receipt of cancer treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Management of erectile dysfunction secondary to treatment for localized prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Urinary incontinence following treatment of localized prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Screening for prostate cancer with prostate-specific antigen: beware the biases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Development of a comorbidity index using physician claims data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Differences in socioeconomic status and survival among white and black men with prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Trends and black/white differences in treatment for nonmetastatic prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Factors that determine the treatment for local and regional prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

The Patterns of Care Survey of radiation therapy in localized prostate cancer: similarities between the practice nationally and in minority-rich areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Radiation therapy in non-surgically-treated nonmetastatic prostate cancer: geographic and demographic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Decision-making strategies for patients with localized prostate cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

The ten-year rule revisited: accuracy of clinicians’ estimates of life expectancy in patients with localized prostate cancer

26 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

21 January 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492143

9 December 2018

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Factors Associated With Initial Therapy for Clinically Localized Prostate Cancer: Prostate Cancer Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

The dynamics of prostate specific antigen during watchful waiting of prostate carcinoma: a study of 94 Japanese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Understanding and appreciating overdiagnosis in the PSA era

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Eradication of a disease: how we cured symptomless prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Molecular prediction of progression in patients with conservatively managed prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30209.X

Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing

21 January 2018

1 reference

12 December 2020

Ethnic variation in prostate cancer survival in New Mexico

1 reference

12 December 2020

A preliminary report on a patient-preference study to compare treatment options in early prostate cancer

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

10.1111/J.1525-1497.2004.30209.X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference